ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803 69. S7.5-19. Cooper LT Jr, Elamm C, Giant cell myocarditis. Diagnosis and treat- ment. Herz. 2012;37:632 6. S7.5-20. Milei J, Grana D, Fernandez AG, et al. Cardiac involvement in acquired immunodeficiency syndrome a review to push action. The Committee for the Study of Cardiac Involvement in AIDS. Clin Cardiol. 1998;21:465 72. S7.5-21. Yunis NA, Stone VE, Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:145 54. S7.5-22. Huang CN, Yu HH, Chiu SN, et al. Acute myocarditis and ventricular fibrillation as initial presentation of pediatric systemic lupus erythe- matosus. Rheumatol Int. 2013;33:1093 6. S7.5-23. Rassi A Jr, Rassi A, Little WC, Chagas heart disease. Clin Cardiol. 2000;23:883 9. S7.5-24. Muratore C, Rabinovich R, Iglesias R, et al. Implantable cardioverter defibrillators in patients with Chagas disease: are they different from patients with coronary disease? Pacing Clin Electrophysiol. 1997;20:194 7. S7.5-25. d Avila A, Splinter R, Svenson RH, et al. New perspectives on cath- eter-based ablation of ventricular tachycardia complicating Chagas disease: experimental evidence of the efficacy of near infrared lasers for catheter ablation of Chagas VT. J Interv Card Electrophysiol. 2002;7:23 38. S7.5-26. Kao AC, Krause SW, Handa R, et al. Wearable defibrillator use in heart failure (WIF): results of a prospective registry. BMC Cardiovasc Disord. 2012;12:123. S7.5-27. Feldman AM, Klein H, Tchou P, et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. 